Showing results (201-210 of 215) with videos related to
Sort By:
Pageof 22
Neurology|March 5, 2017
Increased brain-predicted aging in treated HIV diseaseJames H Cole, Jonathan Underwood, Matthan W A Caan, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2018
No Evidence for Accelerated Aging-Related Brain Pathology in Treated Human Immunodeficiency Virus: Longitudinal Neuroimaging Results From the Comorbidity in Relation to AIDS (COBRA) ProjectJames H Cole, Matthan W A Caan, Jonathan Underwood, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2018
Immediate Versus Deferred Switching From a Boosted Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Risk or Age ≥50 Years: Final 96-Week Results of the NEAT022 StudyJosé M Gatell, Lambert Assoumou, Graeme Moyle, et al.Neurology|June 8, 2014
Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditionsEllen C Caniglia, Lauren E Cain, Amy Justice, et al.AIDS (London, England)|May 31, 2024
MAVMET trial: maraviroc and/or metformin for metabolic dysfunction associated fatty liver disease in adults with suppressed HIVLeanne McCabe, James E Burns, Arash Latifoltojar, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 9, 2021
CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort StudiesFabienne Caby, Marguerite Guiguet, Laurence Weiss, et al.BMJ Open|November 22, 2011
A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adultsAngela M Minassian, Rosalind Rowland, Natalie E R Beveridge, et al.HIV Medicine|July 27, 2012
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012Ian Williams, Duncan Churchill, Jane Anderson, et al.Eclinicalmedicine|January 23, 2023
COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2Alex J Szubert, Katrina M Pollock, Hannah M Cheeseman, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|October 10, 2017
Commonly Prescribed Antiretroviral Therapy Regimens and Incidence of AIDS-Defining Neurological ConditionsEllen C Caniglia, Andrew Phillips, Kholoud Porter, et al.Pageof 22